# Rule 5 — R5-M6B Medicine Evidence Audit: YE (Yellow Electricity)

## 1. Document control

| Field | Value |
|-------|--------|
| **Owner** | Dr. Ghanshyam Bakalwar |
| **Phase** | R5-M6B |
| **Audit sequence** | 38 of 38 |
| **Medicine code** | YE |
| **Expected normalized header form** | **`MED=YE`** |
| **Actual normalized owner header** | **ABSENT** (`^MED=YE` **count 0**) |
| **Physical owner-session header (occurrence A)** | **`MED=None` L1426** |
| **Classification** | DOCUMENTATION_ONLY_MEDICINE_AUDIT (canonical **Electricity** category — not conventional oral materia) |
| **Audit record version** | 1.0 |
| **Audit date** | 2026-08-10 |
| **Repository base (EHAS2)** | `1305eb72cbbd2f9861d957e79f30b19f8e612631` |
| **Framework** | [rule-05-medicine-evidence-audit-framework-R5-M6B.md](./rule-05-medicine-evidence-audit-framework-R5-M6B.md) |
| **Index** | [rule-05-medicine-evidence-audit-index-R5-M6B.md](./rule-05-medicine-evidence-audit-index-R5-M6B.md) |
| **Audit sequence authority** | Index §2 / §3 canonical order (not registry JSON array order where it differs) |
| **Verdict code** | `YE_DOCUMENTATION_AUDIT_COMPLETE_CLINICAL_AND_SAFETY_BLOCKED` |
| **Owner-primary posture** | **`PROVISIONAL_OWNER_PRIMARY`** (occurrence **A** only — owner-session **Yellow Electricity** master block indexed as **`MED=None` L1426**) |

**Mandatory normalizer posture:** Canonical index/registry display code **`YE`** maps to **expected** normalized header form **`MED=YE`**. **`^MED=YE` count = 0** in the available normalized owner corpus. Owner-session Yellow Electricity master text is indexed only as **`MED=None` L1426** (jsonl **1767** / len **2946**). This record accepts that block as a **provisional owner-primary electricity-master** occurrence **A** only. **Do not rewrite** the physical header as **`MED=YE`**. **Do not merge** other **`MED=None`** blocks into occurrence **A**. Owner block prose references medicine number **37** vs audit sequence **38/38** — **OPEN** tension. **This classification does not authorize electricity use, route/application, co-administration, or runtime activation.**

**Authority lead:** YE blocked · MED=None electricity master · no MED=YE header · no electricity-use header · no electricity-use authority

---

## 2. Repository / base / registry identity

| Item | Value |
|------|--------|
| **Canonical repository** | `bakalwar/EH_AROGYA_SUTRA_2` |
| **Registry version** | `ehas2-medicine-registry-v2` |
| **Medicine count** | 38 |
| **C11** | Excluded (`registry.v2.manifest.json` → `excludedCodes: ["C11"]`) |
| **Registry identity (YE code in 38-set)** | **VERIFIED** — code `YE` present in v2 registry; **not** owner-source verification |
| **Registry group category** | **`Electricity`** · **`polarity: NEGATIVE`** — **inventory only**; **not** runtime polarity authority |
| **Registry mirror** | **Yellow Electricity** · **`DERIVED_UNVERIFIED`** |
| **Owner-primary verification** | **PARTIAL** — **`PROVISIONAL_OWNER_PRIMARY`** (occurrence **A** only); **`ownerPrimaryVerified: false`** |
| **Provenance (index vocabulary)** | **`INCOMPLETE_NOT_VERIFIED`** |
| **Canonical sequence slot** | **WE → YE** (final canonical medicine) |
| **Canonical audit predecessor** | **WE** — **aligned** (WE wrapper closes **L1423**) |
| **Physical audit predecessor** | **WE** — **`MED=None` L1381** · **aligned** |
| **Canonical audit successor** | **NONE** — **no row 39**; **no next medicine documentation audit in §2 order** |
| **Physical immediate successor** | **`MED=None` L1467** — **GREEN ELECTRICITY (GE)** — **boundary only** (**GE** canonical seq **18** already audited · **not** canonical successor · **not** a new audit target) |
| **Post-cluster physical block** | **`MED=None` L1511** — **Universal Potency Selection Logic** — **not a medicine** |
| **Prior GE artifact** | Merged **GE** documents **YE→GE→Universal** physical geography — **GE artifact unchanged** by this record |

---

## 3. Audit scope and non-authorization banner

This record is a **documentation-only** source and governance audit for **YE** (expected code **`MED=YE`**; physical **`MED=None` L1426**). It:

- Inventories and compares sources; records **technical governance classifications (TGC)** **as documentation**.
- Does **not** clinically validate YE, authorize potency/dosage, **electricity use**, route/application, co-administration, evidence activation, orchestration, or Rule 6 medicine relationships.
- Does **not** treat registry/legacy/dev/API/mock strings as owner-verified clinical truth.
- Does **not** invent a normalized **`MED=YE`** header or relabel unrelated **`MED=None`** blocks as YE.
- **Documentation completion creates no clinical authority and no electricity-use authority.**

**Posture flags (final):**

| Flag | Value |
|------|--------|
| `clinicallyValidated` | `false` |
| `rule5SafetyCoverageComplete` | `false` |
| `ownerPrimaryVerified` | `false` |
| `ownerSourceStatus` | **`LOCATED_REVIEWED`** (index) · **`PROVISIONAL_OWNER_PRIMARY`** — **`MED=None` L1426**; **no `MED=YE` header** |
| `provenanceStatus` | **`INCOMPLETE_NOT_VERIFIED`** |
| `routeAuthority` | `APPLICATION_ROUTE_AUTHORITY_NONE` |
| `routeAuthorized` | `false` |
| `administrationTimingAuthorized` | `false` |
| `dosageAuthorized` | `false` |
| `electricityUseAuthorized` | `false` |
| `potencyAuthorized` | `false` |
| `evidenceActivated` | `false` |
| `rule6MedicineRelationshipAuthority` | `NONE` |
| `runtimeAuthorized` | `false` |

---

## 4. Complete exact-header scan (`^MED=YE`)

Reference: legacy normalized `docs/phase-s5-mm1e/_doctor_medicine_corpus.txt` (read-only pointer; not modified).

| Scan | Result |
|------|--------|
| Pattern **`^MED=YE`** | **Count 0** (entire normalized corpus file) |
| **Occurrence A anchor** | **`MED=None` L1426** · jsonl **1767** · len **2946** · markers **potency,bodyloc,electricity** |
| Semantic identity in bounded body | **YELLOW ELECTRICITY (YE)** · owner medicine number **37** in block prose vs audit sequence **38/38** — **OPEN** |

---

## 5. Candidate separation — do not merge other `MED=None` blocks

| Corpus line | Identity | YE attribution |
|-------------|----------|----------------|
| **L1381** | **WHITE ELECTRICITY (WE)** | **Predecessor only** — **not YE** |
| **L1426** | **YELLOW ELECTRICITY (YE)** | **Occurrence A — `PROVISIONAL_OWNER_PRIMARY`** |
| **L1467** | **GREEN ELECTRICITY (GE)** | **Physical-next boundary only** — separate merged GE audit |
| **L1511** | **Universal Potency Selection Logic** | **Not a medicine block** |
| **L2037** | Dev/production hardening task | **`QUARANTINED_NO_OWNER_MERGE`** |
| Alternate sessions (`5d426b2e…`, `a984cda7…`, etc.) | Agent/engine templates | **`QUARANTINED_NO_OWNER_MERGE`** — **no silent cross-tier merge** into occurrence **A** |

Scattered **YE** mentions in dev selectors, polarity tables, and engine templates elsewhere — **inventory / quarantine only**; **not** co-primary.

---

## 6. Occurrence A — provisional owner-primary boundary map

| Corpus region | Lines | Role |
|---------------|-------|------|
| **Previous physical header** | **WE `MED=None` L1381** | WE master closes **L1423** |
| **Corpus metadata header** | **L1426** | **`MED=None`** + jsonl **1767** / **2946** — **normalizer gap**; **not `MED=YE`** |
| **Inner wrapper open** | **L1429** | `<user_query>` |
| **Cursor/Database save** | **L1432** | **Excluded** — non-clinical metadata |
| **Owner §1–§5** | **L1435–L1461** | Philosophy, affinity, disease clusters, potency §4 table, keyword tags — **inventory only** |
| **§5 / 116k keyword region** | **L1460–L1461** | **Excluded** — non-operational keyword framing |
| **Expert tip** | **L1462–L1463** | **S-Lass+YE** / **S10+YE** hints — **inventory only** |
| **Post-tip owner/agent tail** | — | **NONE** |
| **Wrapper close** | **L1464** | `</user_query>` — **CLOSED** (**CF-YE-003**) |
| **Physical next header** | **`MED=None` L1467** | **GE** master — **bounded occurrence A must not include GE or later blocks** |
| **Transcript byte proof** | jsonl **1767** / len **2946** | **PENDING** |

---

## 7. Sources and provenance

| Source ID | Classification | Reference | Status |
|-----------|----------------|-----------|--------|
| **SRC-YE-OWNER-A** | **`PROVISIONAL_OWNER_PRIMARY`** | **`MED=None` L1426** · wrapper **L1429–L1464** · jsonl **1767** | Located · **no `MED=YE` header** · byte proof **pending** |
| **SRC-YE-REG-V2** | Registry v2 | `medicines.v2.json` **YE** | **`DERIVED_UNVERIFIED`** · **`Electricity`** / **NEGATIVE** — inventory only |
| **SRC-YE-MM2/MM2C/MM3/BOOK/OCR/UCKB** | Unavailable tiers | — | **`NOT_LOCATED_IN_AVAILABLE_TREES`** |
| **SRC-YE-DEV-API** | Dev/API/mock | BP mapping, Python selectors, hardening L2037, multi-engine templates | **`QUARANTINED_NO_OWNER_MERGE`** |

**Unavailable-tier posture:** **`NOT_LOCATED_IN_AVAILABLE_TREES — not substantively reviewed; no Rule 5 credit; no clinical authority; no owner merge`**.

---

## 8. Technical governance classification (`TECHNICAL_GOVERNANCE_CLASSIFICATION`)

**`TECHNICAL_GOVERNANCE_CLASSIFICATION_COUNT: 10`**

| ID | Token |
|----|--------|
| **TGC-YE-001** | `CANONICAL_YE_SEQ38_FINAL_MEDICINE_OWNER_BLOCK_MED_NONE_L1426_JSONL_1767_NO_MED_EQ_YE_HEADER_WE_PHYSICAL_PREDECESSOR_ALIGNED_CANONICAL_SUCCESSOR_NONE` |
| **TGC-YE-002** | `RULE4_AUTHORITY_NONE_ELECTRICITY_MASTER_IDENTITY_NOT_ELECTRICITY_USE_DEV_YE_ROUTING_POLARITY_TASKS_QUARANTINED` |
| **TGC-YE-003** | `IDENTITY_YELLOW_ELECTRICITY_YE_REGISTRY_ELECTRICITY_NEGATIVE_DERIVED_UNVERIFIED_NOT_HEADER_VERIFICATION` |
| **TGC-YE-004** | `POTENCY_OWNER_TABLE_D1_D500_PHASES_REGISTRY_POTENCY_LOGIC_INVENTORY_ONLY_NO_DOSAGE_AUTHORITY` |
| **TGC-YE-005** | `DISEASE_116K_DIGESTIVE_CONSTIPATION_COLIC_FLATULENCE_CLUSTERS_INVENTORY_ONLY_NO_SELECTOR_MAPPING_ACTIVATION` |
| **TGC-YE-006** | `ROUTE_TIMING_DOSAGE_NO_OWNER_APPLICATION_ROUTE_WORDING_APPLICATION_ROUTE_AUTHORITY_NONE_ELECTRICITY_USE_AUTHORIZED_FALSE` |
| **TGC-YE-007** | `RULE6_COMBINATION_INVENTORY_ONLY_S_LASS_YE_S10_YE_EXPERT_TIP_NO_RUNTIME_RELATIONSHIP_EDGE` |
| **TGC-YE-008** | `MM2_MM2C_MM3_BOOK_OCR_UCKB_NOT_LOCATED_FAIL_CLOSED_NO_MERGE_WITH_OWNER_PRIMARY` |
| **TGC-YE-009** | `DEV_TIER_YE_SELECTOR_POLARITY_TABLES_MULTI_ENGINE_TEMPLATES_QUARANTINED_NOT_CO_PRIMARY` |
| **TGC-YE-010** | `FINAL_CANONICAL_YE_NO_SUCCESSOR_VS_PHYSICAL_GE_L1467_UNIVERSAL_L1511_POST_CLUSTER_BOUNDARY_OPEN_NOT_ROW39_TARGET` |

**Index `RECORDED_0`:** documentation audit **complete**; **zero** essential owner clinical decisions; **TGC-YE-001–010** recorded **separately** (count **10**).

---

## 9. Essential owner clinical decisions

**`ESSENTIAL_OWNER_CLINICAL_DECISIONS: NONE — BLOCKED BY MISSING VERIFIED PRIMARY AND RULE 5 SAFETY EVIDENCE`**

- **Essential owner clinical decision count:** **0**
- **No EOD-YE table**
- Registry/dev/cross-tier derivations are **TGC/CF/ME** — **not** owner clinical approval questions.

---

## 10. Registry-derived inventory (`DERIVED_UNVERIFIED` only)

Registry v2 **YE** mirror: Yellow Electricity; digestive/colonic/stimulant electricity narrative in derived strings; **`potency_logic`** bands; **S-Lass+YE** / **S10+YE** temperament hints — **inventory only**.

**Zero** treatment/cure/efficacy/standard-care substitution, mapping, selector, route, timing, dosage, electricity-use, or runtime authority from registry strings alone. **Registry `NEGATIVE` polarity is not runtime polarity authority.**

---

## 11. Quarantined dev/API/mock inventory (not co-primary)

Non-exhaustive — **rejected** for activation:

- Production hardening **`MED=None` L2037** and alternate-session agent/engine blocks
- Python **`select_potency`**, BP→YE routing, multi-engine clinical synthesis templates
- Scattered **YE** enum strings in dev polarity tables — **`QUARANTINED_NO_OWNER_MERGE`**

---

## 12. Electricity / route / timing / dosage posture (mandated distinction)

| Concept | YE posture |
|---------|----------------|
| **Electricity identity wording** | Present in owner §1–§2 — **inventory only** |
| **Electricity-use / application authority** | **Absent** — identity **≠** use |
| **Owner bounded route/application protocol** | **Not located** in §1–§5 |
| **Administration timing / frequency** | **Not located** as owner schedule |
| **Potency §4 phase table** | **Inventory only** — **`dosageAuthorized: false`** |
| **Verified electricity-application evidence** | **Absent** |
| **`APPLICATION_ROUTE_AUTHORITY_NONE`** | **Yes** |
| **`electricityUseAuthorized`** | **`false`** |
| **`routeAuthorized` / `administrationTimingAuthorized` / `dosageAuthorized`** | **`false` / `false` / `false`** |

---

## 13. Rule 4 / Rule 5 / Rule 6 posture

| Rule | Posture |
|------|---------|
| **Rule 4** | **`RULE4_AUTHORITY_NONE`** — dev/registry Rule strings **quarantined** |
| **Rule 5 safety** | **`SOURCE_NOT_FOUND`** for YE-specific verified owner safety text; unavailable tiers **zero credit**; **`rule5SafetyCoverageComplete: false`** |
| **Rule 6** | **S-Lass+YE**, **S10+YE** expert/combo hints — **inventory only**; **no runtime relationship edge** |

**Clinical / safety / evidence:** **NO / NO / NONE**

---

## 14. Conflict register (`CF-YE`)

| ID | Status | Summary |
|----|--------|---------|
| **CF-YE-001** | **OPEN** | No **`^MED=YE`** vs located owner block **`MED=None` L1426** / jsonl **1767** |
| **CF-YE-002** | **OPEN** | Owner prose medicine number **37** vs canonical audit sequence **38/38** |
| **CF-YE-003** | **CLOSED** | Inner wrapper **`</user_query>` L1464** before **GE `MED=None` L1467** |
| **CF-YE-004** | **OPEN** | Declared len **2946** / jsonl **1767** — **byte proof pending** |
| **CF-YE-005** | **OPEN** | Registry **`NEGATIVE`** / derived mirror vs owner stimulant/digestive narrative |
| **CF-YE-006** | **OPEN** | **Canonical audit successor NONE** vs physical **GE L1467** / **Universal L1511** post-cluster geography |
| **CF-YE-007** | **OPEN** | Dev **L2037** / alternate-session **`MED=None`** vs single owner occurrence **A** |
| **CF-YE-008** | **OPEN** | **MM2/MM2C/MM3/BOOK/UCKB** **not located** in available trees |
| **CF-YE-009** | **OPEN** | High-stakes digestive clusters + **S-Lass+YE** / **S10+YE** tips vs Rule 6 **none** |
| **CF-YE-010** | **OPEN** | Final **38-set** documentation sequence complete vs **L1→WE→YE→GE→Universal** physical walk tension |
| **CF-YE-011** | **CLOSED** | Dev/API **YE** default selectors, polarity tables, template engines — **governance rejection** |
| **CF-YE-012** | **CLOSED** | Non-owner agent-task, hardening, scoring-engine, and alternate-session YE mentions excluded from owner merge (governance exclusion only) |

**Occurrence A post-tip tail:** **NONE** — **CF-YE-012** does **not** close an owner-block agent tail.

**Mandatory CF summary:** CF: 001–010 OPEN (10 entries) · 011–012 CLOSED (2 entries; governance rejections/exclusions only)

---

## 15. Missing-evidence register (`ME-YE`)

| ID | Status | Summary |
|----|--------|---------|
| **ME-YE-001** | **OPEN** | Byte-verified jsonl **1767** / len **2946** for occurrence **A** |
| **ME-YE-002** | **OPEN** | License/publication/redistribution for owner electricity master text |
| **ME-YE-003** | **OPEN** | YE-specific **Rule 5** owner safety (digestive/high-stakes wording) |
| **ME-YE-004** | **OPEN** | **Electricity application** evidence — **no** verified use/route protocol |
| **ME-YE-005** | **OPEN** | Potency phase table vs future owner §4 reconciliation |
| **ME-YE-006** | **OPEN** | **S-Lass+YE** / **S10+YE** vs validated Rule 6 edges |
| **ME-YE-007** | **OPEN** | Owner medicine number **37** vs audit sequence **38/38** reconciliation |
| **ME-YE-008** | **OPEN** | **`MED=YE` normalizer** vs accepted **`MED=None` L1426** indexing policy |
| **ME-YE-009** | **OPEN** | Final canonical **NONE** successor vs **GE** / **Universal** physical tail |
| **ME-YE-010** | **OPEN** | MM2/MM2C/MM3/BOOK/UCKB bibliographic location — **not located** |

Evidence gaps only — **not** EODs.

**Mandatory ME summary:** ME: 001–010 OPEN (10 entries)

---

## 16. Audit footer (mandatory)

| Item | Value |
|------|--------|
| Medicine | YE (38/38) · expected **`MED=YE`** · physical **`MED=None` L1426** |
| Canonical main SHA | `1305eb72cbbd2f9861d957e79f30b19f8e612631` |
| Verdict | `YE_DOCUMENTATION_AUDIT_COMPLETE_CLINICAL_AND_SAFETY_BLOCKED` |
| Owner-primary | **`PROVISIONAL_OWNER_PRIMARY`** (occurrence **A** @ **`MED=None` L1426**) · **`LOCATED_REVIEWED`** (provisional) · **no `MED=YE` header** |
| `ownerPrimaryVerified` | **`false`** |
| Provenance | **`INCOMPLETE_NOT_VERIFIED`** |
| Essential owner clinical decisions | **NONE — BLOCKED…** (**count 0** · **`RECORDED_0`**) |
| TGC | **TGC-YE-001–010** · count **10** |
| Clinical / safety / evidence | **NO / NO / NONE** |
| Mapping flags | **all false** |
| Route / timing / dosage / electricity / Rule 6 / runtime | **NONE / false / false / false / NONE / false** |
| CF | **001–010 OPEN (10 entries) · 011–012 CLOSED (2 entries; governance rejections/exclusions only)** |
| ME | **001–010 OPEN (10 entries)** |
| Canonical audit successor | **NONE** — **final medicine in §2 order**; **no row 39** |
| Physical GE / Universal boundary | **`MED=None` L1467** (GE) · **L1511** (Universal Potency) — **not** canonical successors · **not** new audit targets |
| Registry / runtime changed | **NO** |
| PHI / secrets / database | **NONE** |

**Authority tag:** DOCUMENTATION_ONLY_MEDICINE_AUDIT · **YE blocked · MED=None electricity master · no MED=YE header · no electricity-use header · no electricity-use authority · zero essential owner clinical decisions · canonical 38-set documentation audit sequence complete (38/38); canonical audit successor NONE**

**TABLE_ERROR_COUNT:** 0
